Katagiri, T., Tsukamoto, S., & Kuratani, M. (2021). Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders. Biomedicines.
Chicago Style CitationKatagiri, Takenobu, Sho Tsukamoto, i Mai Kuratani. "Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) As a Target for Human Disorders." Biomedicines 2021.
Cita MLAKatagiri, Takenobu, Sho Tsukamoto, i Mai Kuratani. "Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) As a Target for Human Disorders." Biomedicines 2021.
Atenció: Aquestes cites poden no estar 100% correctes.